NCT02651454View on ClinicalTrials.gov

A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 2, 2020

Study Completion Date

December 2, 2020

Conditions
Metabolic SyndromeObesity
Interventions
DRUG

Daesiho-tang

Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

DRUG

Chowiseungcheng-tang

Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: Hanzung Pharmaceutical. co. Ltd.

DRUG

Placebo

Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Trial Locations (1)

Unknown

Gachon University Gil Oriental Medical Hospital, Incheon

All Listed Sponsors
collaborator

Sangji University Oriental Medical Hospital, Korea

UNKNOWN

collaborator

DongGuk University

OTHER

lead

Gachon University Gil Oriental Medical Hospital

OTHER

NCT02651454 - A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial - | Biotech Hunter | Biotech Hunter